Cargando…

Three Doses of COVID-19 Vaccines: A Retrospective Study Evaluating the Safety and the Immune Response in Patients with Multiple Sclerosis

Since the beginning of the mass immunization of patients with multiple sclerosis (MS), many data on the efficacy and safety of COVID-19 vaccines have been produced. Considering that MS is an autoimmune disease and that some disease-modifying therapies (DMTs) could decrease the antibody response agai...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maniscalco, Giorgia Teresa, Di Giulio Cesare, Daniele, Liguori, Valerio, Manzo, Valentino, Prestipino, Elio, Salvatore, Simona, Di Battista, Maria Elena, Moreggia, Ornella, Ziello, Antonio Rosario, Andreone, Vincenzo, Scavone, Cristina, Capuano, Annalisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342738/ https://www.ncbi.nlm.nih.gov/pubmed/37445269 http://dx.doi.org/10.3390/jcm12134236

Ejemplares similares

Influenza Vaccine Hesitancy in Patients with Multiple Sclerosis: A Monocentric Observational Study
por: Ziello, Antonio, et al.
Publicado: (2021)

Severe Multiple Sclerosis Relapse After COVID-19 Vaccination: A Case Report
por: Maniscalco, Giorgia T., et al.
Publicado: (2021)

The Safety Profile of COVID-19 Vaccines in Patients Diagnosed with Multiple Sclerosis: A Retrospective Observational Study
por: Maniscalco, Giorgia Teresa, et al.
Publicado: (2022)

Humoral efficacy of the third SARS-CoV-2 vaccine dose in Multiple Sclerosis subjects undergoing different disease-modifying therapies
por: Maniscalco, Giorgia Teresa, et al.
Publicado: (2022)

Long term persistence of SARS-CoV-2 humoral response in multiple sclerosis subjects
por: Maniscalco, Giorgia Teresa, et al.
Publicado: (2022)

Interferon Beta-1a treatment promotes SARS-CoV-2 mRNA vaccine response in multiple sclerosis subjects
por: Maniscalco, Giorgia Teresa, et al.
Publicado: (2022)

Hepatobiliary Adverse Reactions during Treatment with Cladribine: Analysis of Data from the European Spontaneous Reporting System
por: Velișcu, Elena Mirabela, et al.
Publicado: (2023)

The Impact of Covid-19 Lockdown on Stroke Admissions and Treatments in Campania
por: Candelaresi, Paolo, et al.
Publicado: (2021)

Disease-Modifying Therapies (DMTs) in Pregnant and Lactating Women with Multiple Sclerosis: Analysis of Real-World Data from EudraVigilance Database
por: Sportiello, Liberata, et al.
Publicado: (2023)

SARS-Cov-2 infection: Response of human immune system and possible implications for the rapid test and treatment
por: di Mauro, Gabriella, et al.
Publicado: (2020)

Preliminary Results of the FASM Study, an On-Going Italian Active Pharmacovigilance Project
por: Maniscalco, Giorgia Teresa, et al.
Publicado: (2020)

The New Paradigms in Clinical Research: From Early Access Programs to the Novel Therapeutic Approaches for Unmet Medical Needs
por: Scavone, Cristina, et al.
Publicado: (2019)

NSAIDs in patients with viral infections, including Covid-19: Victims or perpetrators?
por: Capuano, Annalisa, et al.
Publicado: (2020)

Investigating the association between neoplasms and MOG antibody-associated disease
por: Trentinaglia, Milena, et al.
Publicado: (2023)

Pillars and Pitfalls of the New Pharmacovigilance Legislation: Consequences for the Identification of Adverse Drug Reactions Deriving From Abuse, Misuse, Overdose, Occupational Exposure, and Medication Errors
por: Sessa, Maurizio, et al.
Publicado: (2018)

Anti-hypertensive drugs deprescribing: an updated systematic review of clinical trials
por: Crisafulli, Salvatore, et al.
Publicado: (2021)

Italian Immunization Goals: A Political or Scientific Heated Debate?
por: Scavone, Cristina, et al.
Publicado: (2018)

Vaccine Hesitancy Among Religious Groups: Reasons Underlying This Phenomenon and Communication Strategies to Rebuild Trust
por: Kibongani Volet, Annie, et al.
Publicado: (2022)

Intra-Arterial Thrombolysis to Improve Final Thrombolysis in Cerebral Infarction Score after Thrombectomy: A Case-Series Analysis
por: Mase, Antonio De, et al.
Publicado: (2023)

The Safety Profiles of Two First-Generation NTRK Inhibitors: Analysis of Individual Case Safety Reports from the FDA Adverse Event Reporting System (FAERS) Database
por: Liguori, Valerio, et al.
Publicado: (2023)

A Pharmacovigilance Study on the Safety of Axicabtagene Ciloleucel Based on Spontaneous Reports from the EudraVigilance Database
por: Rafaniello, Concetta, et al.
Publicado: (2023)

Predictors of Cladribine Effectiveness and Safety in Multiple Sclerosis: A Real-World, Multicenter, 2-Year Follow-Up Study
por: Petracca, Maria, et al.
Publicado: (2022)

Drugs-Induced Pathological Gambling: An Analysis of Italian Spontaneous Reporting System
por: Scavone, Cristina, et al.
Publicado: (2019)

Campania Preventability Assessment Committee (Italy): A Focus on the Preventability of Non-steroidal Anti-inflammatory Drugs' Adverse Drug Reactions
por: Sessa, Maurizio, et al.
Publicado: (2017)

Severe Cutaneous Adverse Drug Reactions Associated with Allopurinol: An Analysis of Spontaneous Reporting System in Southern Italy
por: Scavone, Cristina, et al.
Publicado: (2019)

The Safety Profile of General and Local Anaesthetic Agents: Data Collected during 20 Years of Spontaneous Reporting Activities in the Campania Region (Southern Italy)
por: Gargano, Francesca, et al.
Publicado: (2021)

Safety Monitoring of mRNA COVID-19 Vaccines in Children Aged 5 to 11 Years by Using EudraVigilance Pharmacovigilance Database: The CoVaxChild Study
por: Zinzi, Alessia, et al.
Publicado: (2023)

A telehealth intervention for ensuring continuity of care of pediatric obesity during the CoVid-19 lockdown in Italy
por: Pecoraro, Pierluigi, et al.
Publicado: (2021)

PCSK9 Inhibitors and Neurocognitive Adverse Drug Reactions: Analysis of Individual Case Safety Reports from the Eudravigilance Database
por: di Mauro, Gabriella, et al.
Publicado: (2020)

Did the New Italian Law on Mandatory Vaccines Affect Adverse Event Following Immunization’s Reporting? A Pharmacovigilance Study in Southern Italy
por: Scavone, Cristina, et al.
Publicado: (2018)

Current pharmacological treatments for COVID‐19: What's next?
por: Scavone, Cristina, et al.
Publicado: (2020)

Quinolones-Induced Musculoskeletal, Neurological, and Psychiatric ADRs: A Pharmacovigilance Study Based on Data From the Italian Spontaneous Reporting System
por: Scavone, Cristina, et al.
Publicado: (2020)

The Role of Renin-Angiotensin-Aldosterone System in the Heart and Lung: Focus on COVID-19
por: Mascolo, Annamaria, et al.
Publicado: (2021)

Can a Multidisciplinary Weight Loss Treatment Improve Motor Performance in Children with Obesity? Results from an Observational Study
por: Gallè, Francesca, et al.
Publicado: (2023)

Immune Checkpoint Inhibitors and Immune-Related Adverse Drug Reactions: Data From Italian Pharmacovigilance Database
por: Ruggiero, Rosanna, et al.
Publicado: (2020)

Skin Toxicities Associated with Botulin Toxin Injection for Aesthetic Procedures: Data from the European Spontaneous Reporting System
por: Nicoletti, Maria Maddalena, et al.
Publicado: (2023)

Neurological Manifestations Related to Immune Checkpoint Inhibitors: Reverse Translational Research by Using the European Real-World Safety Data
por: Ruggiero, Rosanna, et al.
Publicado: (2022)

Preventable Cases of Oral Anticoagulant-Induced Bleeding: Data From the Spontaneous Reporting System
por: Mascolo, Annamaria, et al.
Publicado: (2019)

Multisystem Inflammatory Syndrome in Children Following COVID-19 Vaccination: A Sex-Stratified Analysis of the VAERS Database Using Brighton Collaboration Criteria
por: Liguori, Valerio, et al.
Publicado: (2023)

Multidisciplinary Treatment for Childhood Obesity: A Two-Year Experience in the Province of Naples, Italy
por: Gallè, Francesca, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tj067pllf1sc6tvku21s2viui3